Sander S Van Berkel

Title: Sander S Van Berkel: Innovator in Beta-Lactamase Inhibitors

Introduction

Sander S Van Berkel is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit metallo-beta-lactamase. His work is crucial in enhancing the effectiveness of beta-lactam antibiotics against bacterial infections.

Latest Patents

Sander S Van Berkel holds a patent for Beta lactamase inhibitors. This patent describes a compound which is a thienolate of formula (I) or a pharmaceutically acceptable salt thereof. The compound is found to be useful in inhibiting metallo-beta-lactamase, thereby potentiating the activity of beta-lactamase antibiotics. The compound can be utilized alone or in combination with a rhodanine of formula (II) or a pharmaceutically acceptable salt thereof. This innovation provides a method for the treatment or prevention of bacterial infections in conjunction with beta-lactam antibiotic agents.

Career Highlights

Sander S Van Berkel is associated with Oxford University Innovation Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on antibiotic efficacy and bacterial resistance.

Collaborations

Sander has collaborated with notable colleagues, including Jürgen Brem and Michael Arnold McDonough. Their combined expertise contributes to the innovative research being conducted at Oxford University Innovation Limited.

Conclusion

Sander S Van Berkel's contributions to the field of pharmaceuticals, particularly through his patent on Beta lactamase inhibitors, highlight his role as an influential inventor. His work is essential in the ongoing battle against bacterial infections and antibiotic resistance.